Association of single nucleotide polymorphisms with efficacy in nivolumab-treated NSCLC patients

被引：0
|
作者：
Basak, E. A. [1 ]
Bins, S. [1 ]
El Bouazzaoui, S. [2 ]
Koolen, S. L. W. [1 ]
Oomen-De Hoop, E. [1 ]
van der Leest, C. [3 ]
van der Veldt, A. A. M. [1 ]
Sleijfer, S. [1 ]
Debets, R. [1 ]
van Schaik, R. H. N. [2 ]
Mathijssen, R. H. J. [1 ]
Aerts, J. G. J. V. [4 ]
机构：
[1] Erasmus MC Canc Inst, Med Oncol, Rotterdam, Netherlands
[2] Erasmus Univ, Clin Chem, Med Ctr, Rotterdam, Netherlands
[3] Amphia Hosp, Pulmonol, Breda, Netherlands
[4] Erasmus Univ, Pulmonol, Med Ctr, Rotterdam, Netherlands
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1378P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Association between single nucleotide polymorphisms and side effects in nivolumab treated NSCLC patients
    Bins, S.
    Basak, E. A.
    El Bouazzaoui, S.
    Koolen, S. L. W.
    van der Leest, C.
    Sleijfer, S.
    Debets, R.
    van Schaik, R. H. N.
    Aerts, J. G. J. V.
    Mathijssen, R.
    ANNALS OF ONCOLOGY, 2016, 27
  • [2] Association between single-nucleotide polymorphisms and adverse events in nivolumab-treated non-small cell lung cancer patients
    Sander Bins
    Edwin A. Basak
    Samira el Bouazzaoui
    Stijn L. W. Koolen
    E. Oomen – de Hoop
    Cor H. van der Leest
    Astrid A. M. van der Veldt
    Stefan Sleijfer
    Reno Debets
    Ron H. N. van Schaik
    Joachim G. J. V. Aerts
    Ron H. J. Mathijssen
    British Journal of Cancer, 2018, 118 : 1296 - 1301
  • [3] Association between single-nucleotide polymorphisms and adverse events in nivolumab-treated non-small cell lung cancer patients
    Bins, Sander
    Basak, Edwin A.
    el Bouazzaoui, Samira
    Koolen, Stijn L. W.
    Hoop, E. Oomen-de
    van der Leest, Cor H.
    van der Veldt, Astrid A. M.
    Sleijfer, Stefan
    Debets, Reno
    van Schaik, Ron H. N.
    Aerts, Joachim G. J. V.
    Mathijssen, Ron H. J.
    BRITISH JOURNAL OF CANCER, 2018, 118 (10) : 1296 - 1301
  • [4] Single nucleotide polymorphisms in PD-L1 and outcome in nivolumab-treated advanced non-small-cell lung cancer patients
    Nomizo, T.
    Funazo, T.
    Ozasa, H.
    Tsuji, T.
    Yasuda, Y.
    Yoshida, H.
    Sakamori, Y.
    Nagai, H.
    Hirai, T.
    Kim, Y. H.
    ANNALS OF ONCOLOGY, 2017, 28
  • [5] Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma
    Sangro, Bruno
    Melero, Ignacio
    Wadhawan, Samir
    Finn, Richard S.
    Abou-Alfa, Ghassan K.
    Cheng, Ann-Lii
    Yau, Thomas
    Furuse, Junji
    Park, Joong-Won
    Boyd, Zachary
    Tang, Hao Tracy
    Shen, Yun
    Tschaika, Marina
    Neely, Jaclyn
    El-Khoueiry, Anthony
    JOURNAL OF HEPATOLOGY, 2020, 73 (06) : 1460 - 1469
  • [6] EGFR-TK1-Associated Interstitial Pneumonitis in Nivolumab-Treated Patients with NSCLC: When Is it Worth The Risk?
    Mormile, Raffaella
    PATHOLOGY & ONCOLOGY RESEARCH, 2019, 25 (04) : 1665 - 1666
  • [7] The impact of nutritional status in nivolumab-treated patients with advanced esophageal cancer
    Takegawa, Naoki
    Hirabayashi, Taku
    Tanaka, Shunta
    Nishikawa, Michiko
    Tokuyama, Nagahiro
    Mimura, Takuya
    Kushida, Saeko
    Tsumura, Hidetaka
    Yamamoto, Yoshinobu
    Miki, Ikuya
    Tsuda, Masahiro
    PLOS ONE, 2023, 18 (05):
  • [8] Association of VEGF single-nucleotide polymorphisms (SNPs) with response and toxicity in patients treated with bevacizumab
    Sun, M.
    Falchook, G. S.
    Wheler, J. J.
    Hong, D. S.
    Piha-Paul, S. A.
    Tsimberidou, A. M.
    Naing, A.
    Fu, S.
    Moulder, S. L.
    Wen, S.
    Mueller, P.
    Kurzrock, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [9] Association of digital and manual quantification of tumor PD-L1 expression with outcomes in nivolumab-treated patients
    Duan, Chunzhe
    Montalto, Michael
    Lee, George
    Pandya, Dimple
    Cohen, Daniel
    Chang, Han
    Tang, Hao
    Agrawal, Nishant
    Elliott, Hunter
    Glass, Benjamin
    Wapinski, Ilan
    Edwards, Robin
    Beck, Andrew H.
    Baxi, Vipul
    CANCER RESEARCH, 2020, 80 (16)
  • [10] MET Amplification and Efficacy of Nivolumab in Patients With NSCLC
    Yoshimura, Katsuhiro
    Inoue, Yusuke
    Inui, Naoki
    Karayama, Masato
    Yasui, Hideki
    Hozumi, Hironao
    Suzuki, Yuzo
    Furuhashi, Kazuki
    Fujisawa, Tomoyuki
    Enomoto, Noriyuki
    Nakamura, Yutaro
    Sugimura, Haruhiko
    Suda, Takafumi
    JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (11):
12345